AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012
Jun 6, 2012
30583_dirs_2012-06-06_caa2d557-f766-4db2-b6c2-9f13c3661ec2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-06-06
Reporting Person: Wood Mark (VP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-06 | Common Stock | M | 1250 | — | Acquired | 32364 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-06 | Restricted Stock Units | $0 | M | 1250 | Disposed | Common Stock (1250) | Direct |
Footnotes
F1: Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted May 22, 2008.
F2: Original grant of restricted stock units vest 1/4th each on July 7, 2009, June 6, 2010, June 6, 2011, and June 6, 2012.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19